S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Merck & Co., Inc. (MRK) News Today

$128.84
-0.61 (-0.47%)
(As of 02/26/2024 ET)
SourceHeadline
reuters.com logoMerck's Bridion faces generic threat from drugmaker Hikma
reuters.com - February 26 at 5:57 PM
marketbeat.com logoRoundview Capital LLC Sells 11,167 Shares of Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 26 at 5:45 PM
msn.com logoWhy Is Cancer-Focused NGM Biopharmaceuticals Stock Trading Lower On Monday?
msn.com - February 26 at 2:48 PM
finance.yahoo.com logoMMC Mar 2024 210.000 put
finance.yahoo.com - February 26 at 1:46 PM
investorplace.com logo3 Top Pharma Stocks for Investors Betting on a Biotech Boom
investorplace.com - February 26 at 11:29 AM
marketbeat.com logoMQS Management LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 25 at 11:44 AM
finance.yahoo.com logoNew York attorney general urges stronger safety warning on asthma drug Singulair
finance.yahoo.com - February 23 at 5:40 PM
marketbeat.com logoEpoch Investment Partners Inc. Has $140.36 Million Position in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 23 at 4:46 PM
markets.businessinsider.com logoMerck Says Keytruda Combination Gets Positive EU CHMP Opinion As Neoadjuvant Treatment For NSCLC
markets.businessinsider.com - February 23 at 9:42 AM
businesswire.com logoMerck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for the Treatment of Resectable NSCLC at High Risk of Recurrence
businesswire.com - February 23 at 6:20 AM
MarketBeat logoMerck & Co., Inc. (NYSE:MRK) Expected to Earn Q1 2025 Earnings of $2.29 Per Share
americanbankingnews.com - February 23 at 2:38 AM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Buys 402,110 Shares of Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 22 at 4:58 PM
finance.yahoo.com logoModerna CEO: 2024 is year of growth, with 2023 transition in rearview
finance.yahoo.com - February 22 at 1:24 PM
investors.com logoInvestors Cash In Fast On 10 Large Stocks With Insane Momentum
investors.com - February 22 at 8:00 AM
marketbeat.com logoZacks Research Comments on Merck & Co., Inc.'s Q1 2025 Earnings (NYSE:MRK)
marketbeat.com - February 22 at 7:50 AM
marketbeat.com logoMerck & Co., Inc. Q4 Earnings Transcript
marketbeat.com - February 22 at 7:00 AM
fool.com logo2 Monster Stocks to Buy Without Any Hesitation
fool.com - February 22 at 6:45 AM
MarketBeat logoZacks Research Weighs in on Merck & Co., Inc.'s Q1 2024 Earnings (NYSE:MRK)
americanbankingnews.com - February 22 at 1:18 AM
marketbeat.com logoAdvent Capital Management DE Invests $3.09 Million in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 21 at 7:39 PM
marketbeat.com logoMerck & Co., Inc. (NYSE:MRK) Expected to Earn Q1 2024 Earnings of $2.07 Per Share
marketbeat.com - February 21 at 7:42 AM
marketbeat.com logoMerck & Co., Inc. (NYSE:MRK) Shares Sold by Citizens Financial Group Inc. RI
marketbeat.com - February 20 at 3:48 PM
finance.yahoo.com logoFDA Grants Priority Review to Merck's Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Treatment for Primary Advanced or Recurrent Endometrial Carcinoma
finance.yahoo.com - February 20 at 8:52 AM
investors.com logo8 Companies' Profit Is Expected To Outgrow Even Nvidia's This Year
investors.com - February 20 at 8:00 AM
businesswire.com logoFDA Grants Priority Review to Merck's Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Treatment for Primary Advanced or Recurrent Endometrial Carcinoma
businesswire.com - February 20 at 6:45 AM
marketbeat.com logoBrandywine Global Investment Management LLC Reduces Stake in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 19 at 1:45 PM
marketbeat.com logoCI Investments Inc. Increases Stock Position in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 18 at 12:44 PM
marketbeat.com logoMerck & Co., Inc. (NYSE:MRK) Stock Position Increased by Chiron Investment Management LLC
marketbeat.com - February 18 at 10:49 AM
finance.yahoo.com logoWith 78% ownership, Merck & Co., Inc. (NYSE:MRK) boasts of strong institutional backing
finance.yahoo.com - February 18 at 9:10 AM
MarketBeat logoMerck & Co., Inc. (NYSE:MRK) Sets New 12-Month High at $128.09
americanbankingnews.com - February 18 at 4:42 AM
marketbeat.com logoRichard P Slaughter Associates Inc Raises Position in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 16 at 8:34 PM
marketbeat.com logoMerck & Co., Inc. (NYSE:MRK) Reaches New 52-Week High at $128.09
marketbeat.com - February 16 at 2:56 PM
finance.yahoo.com logo15 Best Hospitals for Cancer Treatment in the US
finance.yahoo.com - February 16 at 7:47 AM
money.usnews.com logoMerck & Co Inc
money.usnews.com - February 16 at 2:45 AM
finance.yahoo.com logoMerck & Co Inc EVP & CFO Caroline Litchfield Sells 38,291 Shares
finance.yahoo.com - February 16 at 12:51 AM
marketbeat.com logoKorea Investment CORP Purchases 115,906 Shares of Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 15 at 7:52 PM
investorplace.com logo3 Inflation-Proof Stock Picks Following Tuesday's CPI Report
investorplace.com - February 15 at 2:09 PM
marketbeat.com logoCantor Fitzgerald Reaffirms Overweight Rating for Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 14 at 12:27 PM
finance.yahoo.com logoMerck Insiders Sell US$15m Of Stock, Possibly Signalling Caution
finance.yahoo.com - February 14 at 7:40 AM
marketbeat.com logoTeam Hewins LLC Makes New $2.31 Million Investment in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 13 at 1:27 PM
marketbeat.com logoMontag A & Associates Inc. Lowers Stake in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 12 at 3:35 PM
finance.yahoo.com logoHealth Canada Approves KEYTRUDA® in combination with trastuzumab and chemotherapy, as a first-line treatment for patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma whose tumours express PD-L1 (CPS ≥ 1)
finance.yahoo.com - February 12 at 9:26 AM
marketbeat.com logoMerck & Co., Inc. (NYSE:MRK) Shares Sold by Nichols & Pratt Advisers LLP MA
marketbeat.com - February 11 at 11:50 AM
finance.yahoo.com logo14 Best US Stocks For Foreign Investors
finance.yahoo.com - February 11 at 9:20 AM
marketbeat.com logoMerck & Co., Inc. (NYSE:MRK) Shares Bought by Homestead Advisers Corp
marketbeat.com - February 10 at 11:33 AM
finance.yahoo.com logoMerck & Co., Inc.'s (NYSE:MRK) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
finance.yahoo.com - February 10 at 8:40 AM
marketbeat.com logoSkandinaviska Enskilda Banken AB publ Reduces Holdings in Merck & Co., Inc. (NYSE:MRK)
marketbeat.com - February 9 at 6:48 PM
markets.businessinsider.com logoAnalysts’ Top Healthcare Picks: Merck & Company (MRK), Omnicell (OMCL)
markets.businessinsider.com - February 9 at 6:38 PM
finance.yahoo.com logoMerck & Co Inc EVP, Chief Info & Digital Officer David Williams Sells 1,451 Shares
finance.yahoo.com - February 9 at 1:37 PM
finance.yahoo.com logoMERCK CANADA ANNOUNCES COLLABORATION WITH VECTOR INSTITUTE TO FURTHER ADVANCE ITS ARTIFICIAL INTELLIGENCE CAPABILITIES AND DRIVE INNOVATION IN HEALTHCARE
finance.yahoo.com - February 8 at 8:57 AM
marketbeat.com logoAre these frigid Dow stocks in for a longer winter? (MRK)
marketbeat.com - February 8 at 7:12 AM
Get Merck & Co., Inc. News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.

This is the #1 Stock to Buy for the AI Tidal Wave (Ad)

Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.

Learn more here.

MRK Media Mentions By Week

MRK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRK
News Sentiment

1.03

0.45

Average
Medical
News Sentiment

MRK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRK Articles
This Week

28

14

MRK Articles
Average Week

Get Merck & Co., Inc. News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:MRK) was last updated on 2/26/2024 by MarketBeat.com Staff

From Our Partners